The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...

The All Member Meeting featured a great mix of speakers - Jess Mills of Act for Cancer; and Mary-Jo Pryor of NHSE Specialised...

Slides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical...

It was great to see some of you at the Britain Against Cancer conference on 4 December and thank you to those of you – or your patients -...

When a person is diagnosed with cancer in the UK information about them is automatically included in their national cancer registry. It...

The annual All Stakeholder Briefing was held on 17 October 2018. We were honoured that Cally Palmer, National Cancer Director, NHS...

Following the successful visit to West Yorkshire & Harrogate Cancer Alliance on Thursday 4 October, the presentations delivered on the...

This film was made to ensure that all the learnings from the workshop "Getting data out for rare and less common cancers" we organised...